GSP® Instrument

GSP Neonatal Creatine Kinase -MM kit

Request for more information

PerkinElmer’s new assay measures muscle specific creatine kinase in dried blood spots, helping to detect newborns affected by Duchenne Muscular Dystrophy

PerkinElmer’s GSP® Neonatal Creatine Kinase –MM kit is an immunoassay for measuring CK-MM in dried blood spot samples of newborn babies. As the assay measures the muscle specific isoform, it enables the screening process to find the babies affected by DMD. The kit is available on PerkinElmer’s GSP® instrument, a fully automated, high throughput biochemical analyzer. 

Why is early detection of Duchenne Muscular dystrophy so important?
Early screening prevents unnecessary diagnostic odysseys and allows appropriate early interventions and clinical surveillance. Recent therapeutic developments for DMD, along with new evidence of the importance of early intervention with therapy, such as corticosteroid treatment, have underscored the need for newborn screening of DMD. 

Product number: 3311-0010
GSP Neonatal Creatine Kinease -MM kit

Benefits of the assay

The first CE-IVD kit for Duchenne Muscular Dystrophy screening
Fully automated – no reagent preparation
High sensitivity and specificity – good separation between affected and unaffected cases
Wide measuring range enabling numerical result also from most of the non-affected cases
Kit includes reagents, QC material and specific QC certificates
Robust and reliable DELFIA® performance
Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.